Korean Circ J.  2018 Oct;48(10):944-946. 10.4070/kcj.2018.0158.

A New Era of Targeting Pathogenic Immune Mechanisms in Cardiovascular Disease

• Park MS
• Youn JC

• KMID: 2420647
• DOI: http://doi.org/10.4070/kcj.2018.0158

Abstract

No abstract available.

MeSH Terms

Cardiovascular Diseases*

Reference

1. Kang NJ, Han SC, Kang HJ, et al. Anti-inflammatory effect of 3-Bromo-4,5-dihydroxybenzaldehyde, a component of polysiphonia morrowii, in vivo and in vitro. Toxicol Res. 2017; 33:325–332.

2. Ji N, Lou H, Gong X, Fu T, Ni S. Treatment with 3-bromo-4, 5-dihydroxybenzaldehyde improves cardiac function by inhibit macrophage infiltration in mice. Korean Circ J. 2018; 48:933–943.

3. Frangogiannis NG. The inflammatory response in myocardial injury, repair, and remodelling. Nat Rev Cardiol. 2014; 11:255–265.

4. Giugliano GR, Giugliano RP, Gibson CM, Kuntz RE. Meta-analysis of corticosteroid treatment in acute myocardial infarction. Am J Cardiol. 2003; 91:1055–1059.

5. Huang S, Frangogiannis NG. Anti-inflammatory therapies in myocardial infarction: failures, hopes and challenges. Br J Pharmacol. 2018; 175:1377–1400.

6. Yu HT, Park S, Shin EC, Lee WW. T cell senescence and cardiovascular diseases. Clin Exp Med. 2016; 16:257–263.

7. Youn JC, Yu HT, Lim BJ, et al. Immunosenescent CD8⁺ T cell and C-X-C chemokines are increased in human hypertension. Hypertension. 2013; 62:126–133.

8. Yu HT, Youn JC, Lee J, et al. Characterization of CD8(+)CD57(+) T cells in patients with acute myocardial infarction. Cell Mol Immunol. 2015; 12:466–473.

9. Youn JC, Han S, Ryu KH. Temporal trends of hospitalized patients with heart failure in Korea. Korean Circ J. 2017; 47:16–24.

10. Youn JC, Kim JY, Jung MK, et al. Analysis of cytomegalovirus-specific T-cell responses in patients with hypertension: comparison of assay methods and antigens. Clin Hypertens. 2018; 24:5.